NYSE: BMY Shareholder Alert: Update in Lawsuit against Bristol-Myers Squibb Co announced by Shareholders Foundation Biotech Investing
New Study in Newborns Finds Nellcor Pulse Oximetry Technology Provides Faster Stable Oxygen Saturation Readings Than Masimo Pulse Oximeter Medical Device Investing
Nextech AR's Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show Medical Device Investing
HempFusion's Chief Marketing Officer, Ms. Ola Lessard, Elected President of The U.S. Hemp Roundtable for Second Consecutive Term Biotech Investing
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Psychedelics Investing
Adjuvant Treatment with Opdivo Demonstrates Statistically Significant and Clinically Meaningful Improvement in Disease-Free Survival in Patients with Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial Biotech Investing
OPDIVO® in Combination with CABOMETYX® Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma in the Phase 3 CheckMate -9ER Trial Biotech Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
